Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CERUS CORP | 207,045 | reported | 03 Jun 2025 | tx 54+853,920−175,613 |
| SUNESIS PHARMACEUTICALS INC | 128,017 | reported | 28 Feb 2024 | tx 67+5,977,861−590,539 |
| Jazz Pharmaceuticals plc | 55,014 | reported | 05 Mar 2023 | tx 21+206,658−32,580 |
| Protagonist Therapeutics, Inc | 45,000 | reported | 26 Oct 2023 | tx 1+45,000 |
| CORCEPT THERAPEUTICS INC | 12,500 | reported | 21 May 2026 | tx 121+405,150−305,300 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | CORCEPT THERAPEUTICS INC | 12,500 | 0.00 USD | deriv |
| 10 Oct 2025 | SALE | CORCEPT THERAPEUTICS INC | 2,200 | 87.54 USD | |
| 10 Oct 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 14.08 USD | |
| 10 Oct 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 0.00 USD | deriv |
| 10 Sept 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 14.08 USD | |
| 10 Sept 2025 | SALE | CORCEPT THERAPEUTICS INC | 2,200 | 72.45 USD | |
| 10 Sept 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 0.00 USD | deriv |
| 11 Aug 2025 | SALE | CORCEPT THERAPEUTICS INC | 2,200 | 72.30 USD | |
| 11 Aug 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 14.08 USD | |
| 11 Aug 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 0.00 USD | deriv |
| 10 Jul 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 14.08 USD | |
| 10 Jul 2025 | SALE | CORCEPT THERAPEUTICS INC | 2,200 | 71.08 USD | |
| 10 Jul 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 0.00 USD | deriv |
| 10 Jun 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 14.08 USD | |
| 10 Jun 2025 | SALE | CORCEPT THERAPEUTICS INC | 2,200 | 70.61 USD | |
| 10 Jun 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 2,200 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | CORCEPT THERAPEUTICS INC | 15,000 | 0.00 USD | deriv |
| 03 Jun 2025 | GRANT_AWARD | CERUS CORP | 60,000 | 0.00 USD | |
| 12 May 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 1,800 | 12.13 USD | |
| 12 May 2025 | SALE | CORCEPT THERAPEUTICS INC | 400 | 71.55 USD | |
| 12 May 2025 | SALE | CORCEPT THERAPEUTICS INC | 1,800 | 72.17 USD | |
| 12 May 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 400 | 14.08 USD | |
| 12 May 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 1,800 | 0.00 USD | deriv |
| 12 May 2025 | EXERCISE | CORCEPT THERAPEUTICS INC | 400 | 0.00 USD | deriv |
| 10 Apr 2025 | SALE | CORCEPT THERAPEUTICS INC | 2,200 | 70.22 USD |
5 purchases reported after at least 12 months of silence — most recent on 26 May 2023.